6 results match your criteria: "Mater Dei Hospital Msida Malta.[Affiliation]"
Article Synopsis
- - TNPM (Transient Neonatal Pustular Melanosis) is a harmless condition in newborns that requires no treatment and usually resolves on its own.
- - It's diagnosed based on a specific type of rash that appears as vesicles and pustules, which may leave behind dark spots once healed.
- - In this particular case, the rash displayed more vesiculobullae (larger fluid-filled blisters) instead of the typical pustules, making it an unusual presentation.
Article Synopsis
- The study explores adult perspectives on COVID-19 vaccination in Malta, highlighting a rapid vaccination rollout and high booster uptake among participants.
- A survey revealed that most participants perceived the vaccine as vital for public health, with primary motivations centered on protecting against severe disease, but concerns about side effects were noted, particularly among those hesitant about future boosters.
- The findings suggest that socioeconomic factors influence vaccine hesitancy, emphasizing the need to address safety concerns to improve booster uptake.
Optimizing Liver Division Technique for Procuring Left Lateral Segment Grafts: New Anatomical Insights.
Liver Transpl
February 2021
Diagnostic and Therapeutic Services Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione Palermo Italy Department of Pediatrics Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione Palermo Italy Section of Radiological SciencesDepartment of Biomedicine, Neuroscience and Advanced Diagnostics University of Palermo Palermo Italy Department of Medical Imaging Mater Dei Hospital Msida Malta.
In AP syndrome (APS) with severe thrombocytopenia, rituximab represents a unique drug which can balance the effect of bleeding and thrombosis. By reducing the production of autoantibodies, rituximab can simultaneously raise the platelets and reduce the chance of thrombosis by suppressing APL antibodies. Rituximab can supersede splenectomy as second-line therapy in similar patients.
View Article and Find Full Text PDFThe use of suxamethonium in our case was uneventful and despite craniofacial anomalies, airway management was straightforward. This case illustrates that pediatric patients with trisomy 18, presenting with potentially acute life-threatening conditions and requiring emergency major surgery can be managed successfully with a multidisciplinary approach.
View Article and Find Full Text PDF